Richard A. Paulson, President and CEO at Karyopharm Therapeutics Inc. (KPTI), sold 180,314 shares at $1.17 ($212K) on 2024-02-29, disclosed to the SEC on 2024-03-04.
Open-market sale of $212k KPTI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.17 | 80,470 | $94K | 44.5% |
| 2 | $1.17 | 80,470 | $94K | 44.5% |
| 3 | $1.20 | 19,374 | $23K | 11.0% |
| Total | $1.17 avg | 180,314 | $212K | 100% |
| Filing → |
| KPTI | SELL | 2025-09-16 | $8K | — | Filing → |
| KPTI | SELL | 2025-05-07 | $2K | — | Filing → |
| KPTI | SELL | 2025-04-07 | $916 | — | Filing → |